跳至主要内容
临床试验/NCT07009327
NCT07009327招募中不适用

Efficacy and Safety of Photodynamic Therapy for Cervical Intraepithelial Neoplasia 3(CIN3):A Multicenter Prospective Cohort Study

Peking University Third Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年1月1日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
Efficacy of the treatment

研究概览

简要总结

To investigate the efficacy and safety of photodynamic therapy (20% 5-amino-ketovalerate 630nm red light) in the treatment of cervical intraepithelial neoplasia 3(CIN 3)in women in the real world

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • CIN3, photodynamic therapy was required,
  • type 1 2 transformation area, colposcopy was sufficient
  • the lesion boundary was completely visible
  • The ECC did not indicate high-grade lesions

排除标准

  • coexistence or suspicion of cancer;
  • involving glands
  • Porphyria patients, or suspected allergic to red and blue light.
  • severe medical comorbidities;

结局指标

主要结局

Efficacy of the treatment

时间窗: 1 month after the treatment

colposcopy and biopsy will be performed one month after the treatment. Patients will be categorised as having complete remission(CR) if biopsy confirmed LSIL. If CIN 2 was found after the first course of PDT, it would be categorised as partial remission(PR). Those with the same grade were categorised as persistent disease(PD). The proportion of CR after PDT treatment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验